VAS
MGNX icon

Vestmark Advisory Solutions’s MacroGenics MGNX Stock Holding History

Vestmark Advisory Solutions’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,280
Closed -$232K – 793
2021
Q1 		$232K Buy
+7,280
New +$177K 0.02% 666

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vestmark Advisory Solutions's MGNX Position: Q2 2021 in Review

Vestmark Advisory Solutions sold out of MacroGenics (MGNX) in Q2 2021, closing a stake of 7,280 shares — an estimated $232K sold.

Vestmark Advisory Solutions first reported a position in MGNX in Q1 2021 and held it in 1 quarter. The position peaked at $232K in Q1 2021. 149 funds tracked by Wall St. Rank hold MGNX as of Q2 2021.

  • Vestmark Advisory Solutions reported no remaining MacroGenics position as of Q2 2021 after selling out during the quarter.
  • Vestmark Advisory Solutions sold 7,280 MacroGenics shares in Q2 2021, an estimated $232K.
  • Vestmark Advisory Solutions first reported a position in MacroGenics in Q1 2021 and held it in 1 quarter.
  • Vestmark Advisory Solutions's MacroGenics position peaked at $232K in Q1 2021.
  • 149 funds tracked by Wall St. Rank held MacroGenics as of Q2 2021.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2021, filed 9 Aug 2021.